Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market
Holding RNA?
Track your performance easily

Avidity Biosciences (RNA) Ownership - Who Owns Avidity Biosciences?

663 Followers

Avidity Biosciences (RNA) Ownership Overview

1.24%28.17%0.16%15.43%55.00%
0.16% Other Institutional Investors
15.43% ETFs
55.00% Public Companies and Individual Investors
The ownership structure of Avidity Biosciences (RNA) stock is a mix of institutional, retail, and individual investors. Approximately 43.75% of the company’s stock is owned by Institutional Investors, 1.24% is owned by Insiders, and 55.00% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 09, 2024
xxxxxxxxxxxxx
$1349100
Apr 03, 2024
Arthur Levin
Director
xxxxxxxxxxxxx
$542200
Apr 03, 2024
Sarah Boyce
President & Ceo,director
xxxxxxxxxxxxx
$734720
Mar 21, 2024
Arthur Levin
Director
xxxxxxxxxxxxx
$119800

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$80392
Jun 30, 2024
xxxxxxxxxxxxx
$204250
Jun 30, 2024
xxxxxxxxxxxxx
$26375129
Jun 30, 2024
xxxxxxxxxxxxx
$220606666

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,536,051Institution7.29%385,061,261
5,400,408Institution4.61%243,612,405
5,249,976Institution4.48%236,826,417
4,931,007Institution4.21%222,437,726
4,496,282Institution3.84%202,827,281
4,310,957Institution3.68%194,467,270
3,037,724Institution2.59%137,031,730
2,475,402Institution2.11%111,665,384
2,319,775Institution1.98%104,645,050
1,282,140Institution1.09%57,837,335

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,249,976Institution4.48%236,826,417
4,496,282Institution3.84%202,827,281
4,310,957Institution3.68%194,467,270
3,037,724Institution2.59%137,031,730
2,475,402Institution2.11%111,665,384
1,282,140Institution1.09%57,837,335
1,185,376Institution1.01%53,472,311
1,156,339Institution0.99%52,162,452
1,001,878Institution0.86%45,194,717
974,735Institution0.83%43,970,296

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,525,069Institution3.01%161,906,419
2,796,590Institution2.39%126,154,175
2,122,079Institution1.81%95,811,867
1,755,292Institution1.50%80,620,562
1,390,995Institution1.19%63,888,400
962,570Institution0.82%43,421,533
943,621Institution0.81%43,340,513
767,775Institution0.66%34,634,330
564,722Institution0.48%25,497,198
495,468Institution0.42%22,756,845

FAQ

Who Owns Avidity Biosciences Inc (RNA)?
According to the latest TipRanks data, approximately 0.16% of the company's stock is held by institutional investors, 1.24% is held by insiders, and 55.00% is held by retail investors.
    What percentage of Avidity Biosciences Inc (RNA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.16% of Avidity Biosciences Inc (RNA) stock is held by institutional investors.
      What percentage of Avidity Biosciences Inc (RNA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 55.00% of Avidity Biosciences Inc (RNA) stock is held by retail investors.
        Who owns the most shares of Avidity Biosciences Inc (RNA)?
        Vanguard owns the most shares of Avidity Biosciences Inc (RNA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis